Canis lupus familiaris (dog): 403567
Help
Entry
403567 CDS
T01007
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X2
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
cfa
Canis lupus familiaris (dog)
Pathway
cfa01524
Platinum drug resistance
cfa04010
MAPK signaling pathway
cfa04115
p53 signaling pathway
cfa04148
Efferocytosis
cfa04210
Apoptosis
cfa04215
Apoptosis - multiple species
cfa04623
Cytosolic DNA-sensing pathway
cfa04650
Natural killer cell mediated cytotoxicity
cfa04657
IL-17 signaling pathway
cfa04668
TNF signaling pathway
cfa04726
Serotonergic synapse
cfa04932
Non-alcoholic fatty liver disease
cfa04933
AGE-RAGE signaling pathway in diabetic complications
cfa04936
Alcoholic liver disease
cfa05010
Alzheimer disease
cfa05012
Parkinson disease
cfa05014
Amyotrophic lateral sclerosis
cfa05016
Huntington disease
cfa05020
Prion disease
cfa05022
Pathways of neurodegeneration - multiple diseases
cfa05132
Salmonella infection
cfa05133
Pertussis
cfa05134
Legionellosis
cfa05145
Toxoplasmosis
cfa05146
Amoebiasis
cfa05152
Tuberculosis
cfa05160
Hepatitis C
cfa05161
Hepatitis B
cfa05162
Measles
cfa05163
Human cytomegalovirus infection
cfa05164
Influenza A
cfa05165
Human papillomavirus infection
cfa05167
Kaposi sarcoma-associated herpesvirus infection
cfa05168
Herpes simplex virus 1 infection
cfa05169
Epstein-Barr virus infection
cfa05170
Human immunodeficiency virus 1 infection
cfa05200
Pathways in cancer
cfa05203
Viral carcinogenesis
cfa05205
Proteoglycans in cancer
cfa05206
MicroRNAs in cancer
cfa05210
Colorectal cancer
cfa05222
Small cell lung cancer
cfa05416
Viral myocarditis
cfa05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
cfa00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
403567 (CASP3)
04668 TNF signaling pathway
403567 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
403567 (CASP3)
09143 Cell growth and death
04210 Apoptosis
403567 (CASP3)
04215 Apoptosis - multiple species
403567 (CASP3)
04115 p53 signaling pathway
403567 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
403567 (CASP3)
04650 Natural killer cell mediated cytotoxicity
403567 (CASP3)
04657 IL-17 signaling pathway
403567 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
403567 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
403567 (CASP3)
05206 MicroRNAs in cancer
403567 (CASP3)
05205 Proteoglycans in cancer
403567 (CASP3)
05203 Viral carcinogenesis
403567 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
403567 (CASP3)
05222 Small cell lung cancer
403567 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
403567 (CASP3)
05161 Hepatitis B
403567 (CASP3)
05160 Hepatitis C
403567 (CASP3)
05164 Influenza A
403567 (CASP3)
05162 Measles
403567 (CASP3)
05168 Herpes simplex virus 1 infection
403567 (CASP3)
05163 Human cytomegalovirus infection
403567 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
403567 (CASP3)
05169 Epstein-Barr virus infection
403567 (CASP3)
05165 Human papillomavirus infection
403567 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
403567 (CASP3)
05133 Pertussis
403567 (CASP3)
05134 Legionellosis
403567 (CASP3)
05152 Tuberculosis
403567 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
403567 (CASP3)
05145 Toxoplasmosis
403567 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
403567 (CASP3)
05012 Parkinson disease
403567 (CASP3)
05014 Amyotrophic lateral sclerosis
403567 (CASP3)
05016 Huntington disease
403567 (CASP3)
05020 Prion disease
403567 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
403567 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
403567 (CASP3)
05416 Viral myocarditis
403567 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
403567 (CASP3)
04932 Non-alcoholic fatty liver disease
403567 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
403567 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
403567 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
cfa01002
]
403567 (CASP3)
Enzymes [BR:
cfa01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
403567 (CASP3)
Peptidases and inhibitors [BR:
cfa01002
]
Cysteine peptidases
Family C14: caspase family
403567 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
403567
NCBI-ProteinID:
XP_038308233
Ensembl:
ENSCAFG00000007750
VGNC:
38734
LinkDB
All DBs
Position
16:46413238..46434538
Genome browser
AA seq
302 aa
AA seq
DB search
MGSTFTSGRPEKTWENNGTQVLEVSMENTENSVDAKSFKNAETKILHGSKSMDSGMSFDN
SYKMDYPEMGLCIIINNKNFHKSTGMAPRSGTDVDAANLRETFTNLKYEVRNKNDLTCEE
ILELMNSVSKEDHSKRSSFVCVLLSHGDEGIIFGTNGPVDLRKVTGFFRGDYCRSLTGKP
KLFIIQACRGTELDCGIETDSGIEDDMACQKIPVEADFLYAYSTAPGYYSWRNSKDGSWF
IQSLCAMLKLYAHKLEFMHILTRVNRKVATEFESFSLDSAFHGKKQIPCIVSMLTKELYL
YH
NT seq
909 nt
NT seq
+upstream
nt +downstream
nt
atgggaagtacctttacttctggaaggccagagaagacatgggagaacaacggaacacaa
gtattagaagtatccatggagaacactgaaaactcagtggatgcaaaatcctttaaaaat
gcagaaacaaagatcttacatggaagtaaatcaatggactcgggaatgtccttcgacaac
agttataaaatggattatccagaaatgggtttatgtataataattaataataagaacttt
cataaaagtactggaatggcacctcggtctggtacagatgtagatgcagcaaacctcagg
gaaacattcacaaacttgaaatatgaagtcagaaataaaaatgatctcacatgcgaagaa
attttggaattaatgaacagtgtctctaaagaagatcatagcaaaaggagcagttttgtt
tgcgtgcttctaagccatggggatgaaggaataatttttggaacaaatggacctgttgac
ctgagaaaagtaacaggtttcttccgaggagattactgtagaagtctgactggaaaaccc
aaacttttcattattcaggcctgccgaggtacagaactagactgtggtattgagactgac
agtggaattgaggatgacatggcctgtcagaaaataccagtcgaagcggacttcttgtat
gcttactctacagcccctggttactattcctggcgaaattcaaaggatggatcctggttc
atccagtcactttgtgcgatgctgaaactatacgctcacaagcttgagtttatgcacatt
cttactcgggttaaccgaaaggtcgcaacagaatttgagtccttttctcttgactctgct
tttcatggaaagaaacagattccatgtattgtgtctatgctcacaaaagaactgtatctt
tatcactga
DBGET
integrated database retrieval system